4 Liver Cancer Clinical Trials in Irvine, KY (2026)

Q: How do I join a clinical trial in Irvine?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Irvine research site will contact you.

Recruiting Liver Cancer Studies in Irvine

NCT06109272Recruiting

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading cause of cancer-related death. The majority of participants first presenting with HCC have advanced unresectable or metastatic...

Irvine, KY660 participantsAbbVie

View Study Details

NCT07166406Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

This phase III trial compares the effect of immunotherapy (IO) with stereotactic body radiation therapy (SBRT) to IO alone in treating patients with liver cancer (hepatocellular cancer) that may have ...

Irvine, KY226 participantsNRG Oncology

View Study Details

NCT06811116Recruiting

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

This phase I/II trial studies the side effects and best dose of sapanisertib when given together with cabozantinib, and to see how well they work in treating patients with liver cancer that has spread...

Irvine, KY92 participantsNational Cancer Institute (NCI)

View Study Details

NCT06050252Recruiting

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) t...

Irvine, KY27 participantsNational Cancer Institute (NCI)

View Study Details

About Liver Cancer Clinical Trials in Irvine

Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.

There are currently 4 liver cancer clinical trials recruiting participants in Irvine, KY. These studies are seeking a combined 1,005 participants. Research is being sponsored by AbbVie, NRG Oncology, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Cancer Clinical Trials in Irvine — FAQ

Are there liver cancer clinical trials in Irvine?

Yes, there are 4 liver cancer clinical trials currently recruiting in Irvine, KY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Irvine?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Irvine research site will contact you about next steps.

Are clinical trials in Irvine free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Irvine studies also compensate for your time and travel.

What liver cancer treatments are being tested?

The 4 active trials in Irvine are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.

Data updated July 13, 2026 from ClinicalTrials.gov